David G. Monroe

8.3k total citations · 6 hit papers
80 papers, 5.7k citations indexed

About

David G. Monroe is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, David G. Monroe has authored 80 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 30 papers in Genetics and 20 papers in Physiology. Recurrent topics in David G. Monroe's work include Bone Metabolism and Diseases (30 papers), Estrogen and related hormone effects (28 papers) and Telomeres, Telomerase, and Senescence (19 papers). David G. Monroe is often cited by papers focused on Bone Metabolism and Diseases (30 papers), Estrogen and related hormone effects (28 papers) and Telomeres, Telomerase, and Senescence (19 papers). David G. Monroe collaborates with scholars based in United States, Germany and United Kingdom. David G. Monroe's co-authors include Sundeep Khosla, Merry Jo Oursler, Joshua N. Farr, Daniel G. Fraser, Tamar Tchkonia, James L. Kirkland, Matthew T. Drake, Thomas C. Spelsberg, Robert J. Pignolo and Nathan K. LeBrasseur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David G. Monroe

77 papers receiving 5.6k citations

Hit Papers

Targeting cellular senescence prevents age-related bone ... 2012 2026 2016 2021 2017 2012 2022 2016 2021 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Monroe United States 38 3.0k 1.4k 1.1k 1.0k 979 80 5.7k
Stavroula Kousteni United States 36 3.5k 1.2× 575 0.4× 1.5k 1.3× 1.9k 1.8× 1.5k 1.5× 62 6.6k
Xiang‐Hang Luo China 43 3.5k 1.2× 920 0.7× 1.2k 1.1× 863 0.8× 397 0.4× 127 6.2k
Ling‐Qing Yuan China 46 3.8k 1.3× 942 0.7× 1.7k 1.5× 985 0.9× 487 0.5× 236 7.3k
Dengshun Miao China 46 3.6k 1.2× 734 0.5× 981 0.9× 1.7k 1.6× 1.1k 1.2× 195 7.7k
Riko Kitazawa Japan 39 2.7k 0.9× 434 0.3× 494 0.4× 1.5k 1.4× 720 0.7× 230 5.6k
Rob vanʼt Hof United Kingdom 30 1.9k 0.6× 620 0.4× 829 0.7× 1.1k 1.1× 487 0.5× 95 4.2k
Sohei Kitazawa Japan 47 3.5k 1.1× 588 0.4× 347 0.3× 1.8k 1.7× 722 0.7× 261 7.0k
Nadia Rucci Italy 42 2.7k 0.9× 413 0.3× 494 0.4× 1.5k 1.4× 402 0.4× 107 4.8k
Hua Zhu Ke United States 51 4.5k 1.5× 478 0.3× 2.8k 2.5× 2.8k 2.7× 1.4k 1.5× 126 7.9k
Yihong Wan United States 31 2.8k 0.9× 545 0.4× 421 0.4× 842 0.8× 532 0.5× 73 4.3k

Countries citing papers authored by David G. Monroe

Since Specialization
Citations

This map shows the geographic impact of David G. Monroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Monroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Monroe more than expected).

Fields of papers citing papers by David G. Monroe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Monroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Monroe. The network helps show where David G. Monroe may publish in the future.

Co-authorship network of co-authors of David G. Monroe

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Monroe. A scholar is included among the top collaborators of David G. Monroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Monroe. David G. Monroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Farr, Joshua N., David G. Monroe, Elizabeth J. Atkinson, et al.. (2025). Characterization of Human Senescent Cell Biomarkers for Clinical Trials. Aging Cell. 24(5). e14489–e14489. 5 indexed citations
3.
Farr, Joshua N., Elizabeth J. Atkinson, Sara J. Achenbach, et al.. (2024). Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nature Medicine. 30(9). 2605–2612. 46 indexed citations breakdown →
4.
Doolittle, Madison L., Brittany Eckhardt, Stephanie J. B. Vos, et al.. (2023). Modest Effects of Osteoclast‐Specific ERα Deletion after Skeletal Maturity. JBMR Plus. 7(10). e10797–e10797. 1 indexed citations
5.
Wicik, Zofia, Kevin S. Pitel, Megan Weivoda, et al.. (2023). Estrogen-regulated miRs in bone enhance osteoblast differentiation and matrix mineralization. Molecular Therapy — Nucleic Acids. 33. 28–41. 3 indexed citations
6.
Kaur, Japneet, Dominik Saul, Madison L. Doolittle, et al.. (2023). MicroRNA19a3p Decreases with Age in Mice and Humans and Inhibits Osteoblast Senescence. JBMR Plus. 7(6). e10745–e10745. 10 indexed citations
7.
Englund, Davis A., Zaira Aversa, Xu Zhang, et al.. (2023). Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia. JCI Insight. 9(2). 17 indexed citations
8.
Kaur, Japneet, Dominik Saul, Madison L. Doolittle, et al.. (2022). Identification of a suitable endogenous control miRNA in bone aging and senescence. Gene. 835. 146642–146642. 11 indexed citations
9.
Doolittle, Madison L., David G. Monroe, Joshua N. Farr, & Sundeep Khosla. (2021). The role of senolytics in osteoporosis and other skeletal pathologies. Mechanisms of Ageing and Development. 199. 111565–111565. 32 indexed citations
10.
Aquino-Martínez, Rubén, Jennifer L. Rowsey, Daniel G. Fraser, et al.. (2020). LPS-induced premature osteocyte senescence: Implications in inflammatory alveolar bone loss and periodontal disease pathogenesis. Bone. 132. 115220–115220. 79 indexed citations
11.
Subramaniam, Malayannan, Kevin S. Pitel, Elizabeth S. Bruinsma, David G. Monroe, & John R. Hawse. (2017). TIEG and estrogen modulate SOST expression in the murine skeleton. Journal of Cellular Physiology. 233(4). 3540–3551. 11 indexed citations
12.
Roforth, Matthew M., Sundeep Khosla, & David G. Monroe. (2013). Identification of Rorβ targets in cultured osteoblasts and in human bone. Biochemical and Biophysical Research Communications. 440(4). 768–773. 18 indexed citations
13.
Roforth, Matthew M., Koji Fujita, Salman Kirmani, et al.. (2013). Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans. Bone. 59. 1–6. 94 indexed citations
14.
Fujita, Koji, Matthew M. Roforth, Elizabeth J. Atkinson, et al.. (2013). Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture. Osteoporosis International. 25(3). 887–895. 23 indexed citations
15.
Mödder, Ulrike I., Matthew M. Roforth, Kelley A. Hoey, et al.. (2011). Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone. 49(2). 202–207. 66 indexed citations
16.
Mödder, Ulrike I., Matthew M. Roforth, Kristy M. Nicks, et al.. (2011). Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection. Bone. 50(3). 804–810. 37 indexed citations
17.
Allhoff, Fritz & David G. Monroe. (2007). Food & Philosophy: Eat, Drink, and Be Merry. Blackwell eBooks. 3 indexed citations
18.
Monroe, David G., Frank J. Secreto, John R. Hawse, et al.. (2006). Estrogen Receptor Isoform-specific Regulation of the Retinoblastoma-binding Protein 1 (RBBP1) Gene. Journal of Biological Chemistry. 281(39). 28596–28604. 21 indexed citations
19.
Rickard, David J., David G. Monroe, Terry Ruesink, et al.. (2003). Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors α and β. Journal of Cellular Biochemistry. 89(3). 633–646. 93 indexed citations
20.
Monroe, David G., et al.. (2002). Tissue-Protective Effects of Estrogen Involve Regulation of Caspase Gene Expression. Molecular Endocrinology. 16(6). 1322–1331. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026